• 11/06/2024

    Thank you Wieneke!

    Upon completing her two terms, Wieneke Meijer has stepped down as a Member BoT during the General Assembly of KNCV…

    Lees meer
  • 10/06/2024

    Highlights from our Mini Symposium on Next Generation Sequencing for the diagnosis and surveillance of infectious diseases and antimicrobial drug resistance!

    Genome sequencing is one of the many novel tools that support our fight against AMR, TB and other infectious diseases.

    Lees meer
  • 06/06/2024

    Join us at the European Advanced Course on Clinical Tuberculosis (EACCTB)

      Here you can find the Progam EACCTB 2024. And to register and find…

    Lees meer
  • 06/06/2024

    Launch of KNCV’s self-assessment checklist and planning tool

    KNCV launches a Self-assessment checklist and planning tool to assess the opportunities and barriers for programmatic introduction of the shorter…

    Lees meer
  • 05/06/2024

    New study highlights the impact of Stool-Based Xpert test on childhood TB diagnosis in Nigeria

    A recent study conducted in Nigeria revealed the significant impact of stool-based Xpert testing on childhood tuberculosis…

    Lees meer
  • 29/05/2024

    European Initiative to Accelerate TB Prevention and Screening: A Collaborative Effort

    The European Prevention and Systematic Screening Initiative to End TB (PASS to End TB) is a critical response to the…

    Lees meer
  • 21/05/2024

    Exploring the future of health prioritization: The People-Centred Framework at the Priorities Conference 2024

    The 14th Conference of the International Society for Priorities in Health (ISPH) – Priorities Conference 2024 –,…

    Lees meer
  • 03/05/2024

    Stool-based testing method: A revolutionary, convenient, accurate and pain-free approach to diagnose childhood tuberculosis

    In a recent study, conducted by the Ethiopian Public Health Institute (EPHI), KNCV…

    Lees meer
  • 22/04/2024

    Shorter DR-TB treatment regimens and cardiac monitoring

    Cardiac monitoring for people on novel short DR-TB treatment regimens can be decentralized and accessible. Dealing…

    Lees meer
  • 15/04/2024

    Private sector TB care can better capacity for primary treatment

    With the right incentives and administrative backing, informal healthcare providers and pharmacists can become partners in the country’s public health…

    Lees meer
  • 24/03/2024

    Meet the new TB ambassador for KNCV: Paulina Siniatkina

    Today, on World TB Day, we would like to proudly announce that Paulina Siniatkina will become a TB ambassador for…

    Lees meer
  • 24/03/2024

    Welcome to the KNCV family!

    We acknowledge that impactful work is not done in isolation, and requires different sets of expertise and local knowledge. On…

    Lees meer
  • 24/03/2024

    Digital Adherence Webinar Invitation

    In alignment with of our collective actions towards ending TB, KNCV standing as the…

    Lees meer
  • 05/02/2024

    Call for Application: Web-based application and database consultation service

    KNCV TB Plus is looking for a: Web-based application and database (developer and maintenance) consultation service Background KNCV TB Plus…

    Lees meer
  • 15/01/2024

    Global Fund Approves US$9.2 Billion in New Grants to Accelerate Fight Against HIV, TB and Malaria in More than 70 Countries

    The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$9.2 billion for grants…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.